Research output per year
Research output per year
Personal profile
Headline
Associate Professor
Fingerprint
Dive into the research topics where Cesar Rodriguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
Voorhees, P. M., Sborov, D. W., Laubach, J., Kaufman, J. L., Reeves, B., Rodriguez, C., Silbermann, R., Costa, L. J., Anderson, L. D., Nathwani, N., Shah, N., Bumma, N., Efebera, Y. A., Holstein, S. A., Costello, C., Jakubowiak, A., Wildes, T. M., Orlowski, R. Z., Shain, K. H. & Cowan, A. J. & 8 others, , 2025, In: Future Oncology. 21, 1, p. 25-49 25 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Avigan, Z. M., Bodnar, S., Pan, D., Catlett, J., Richter, J., Sanchez, L. J., Rodriguez, C., Rossi, A. C., Richard, S., Jagannath, S., Cho, H. J., Parekh, S. & Thibaud, S., 14 Jan 2025, In: Blood advances. 9, 1, p. 202-206 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
Pan, D., Mouhieddine, T. H., Sheng, T., Fu, W., Moshier, E., Richter, J., Parekh, S., Jagannath, S., Rossi, A. C., Sanchez, L. J., Thibaud, S., Rodriguez, C., Cho, H. J. & Richard, S., 2025, (Accepted/In press) In: Bone Marrow Transplantation. 161.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma: MULTIPLE MYELOMA, GAMMOPATHIES
Costa, L. J., Banerjee, R., Mian, H., Weisel, K., Bal, S., Derman, B. A., Htut, M. M., Nagarajan, C., Rodriguez, C., Richter, J., Frigault, M. J., Ye, J. C., van de Donk, N. W. C. J., Voorhees, P. M., Puliafito, B., Bahlis, N., Popat, R., Chng, W. J., Ho, P. J. & Kaur, G. & 12 others, , Mar 2025, In: Leukemia. 39, 3, p. 543-554 12 p., 116.Research output: Contribution to journal › Review article › peer-review
22 Scopus citations -
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma
Chen, L. Y., Thibaud, S., Bodnar, S., Chari, A., Richter, J., Cho, H. J., Sanchez, L. J., Rodriguez, C., Rossi, A. C., Richard, S., Parekh, S. & Jagannath, S., 14 Jan 2025, In: Blood advances. 9, 1, p. 176-179 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations
Press/Media
-
Quadruplet Regimen Preferable to Triplets in Multiple Myeloma
27/03/25
1 item of Media coverage
Press/Media
-
Mount Sinai Highlights Key Updates and Trends for Multiple Myeloma Awareness Month 2025
Parekh, S., Richter, J. & Rodriguez, C.
3/03/25
1 item of Media coverage
Press/Media
-
Determining Administration of BCMA, T-Cell Engagers in R/R Multiple Myeloma
27/09/24
1 item of Media coverage
Press/Media